FPN Scholarship Award Update: Dr. Barreras

Exploring small fiber neuropathy.

Paula Barreras, MD, neuroimmunology fellow at Johns Hopkins Hospital, was one of the first recipients of the Foundation for Peripheral Neuropathy’s (FPN) Clinical Research Training Scholarships (CRTS). Through these awards, FPN is supporting early-career researchers in peripheral neuropathy. Did you know that about 40% of people with sarcoidosis, an inflammatory disease, also experience a nerve condition called small fiber neuropathy (SFN)? […]

Read More… from FPN Scholarship Award Update: Dr. Barreras

Clinical Research Training Scholarship Update

CRTS Updates.

Attracting and retaining top research talent is vital to improving therapies for peripheral neuropathy. Some of the brightest researchers are often drawn to well-known disciplines with the largest funding pools – such as cancer research. To combat this challenge, FPN works in partnership with the American Brain Foundation and the American Academy of Neurology to facilitate a Clinical Research Training Scholarship (CRTS). […]

Read More… from Clinical Research Training Scholarship Update

eNews November 2024

Image that reads: FPN E-News.

November is Diabetes Awareness Month, a time dedicated to raising awareness about the causes, risks, and management of diabetes. As the leading cause of peripheral neuropathy, diabetes can have serious implications for nerve health. This month, we’re focusing on education and prevention strategies to help you reduce your risk or manage diabetes more effectively. […]

Read More… from eNews November 2024

Registry’s New Research Findings on Vitamin D

PNRR

Registry’s New Research Findings on Vitamin D The Foundation for Peripheral Neuropathy (FPN) started the Peripheral Neuropathy Research Registry (PNRR) in 2008. The PNRR collects data and samples (like blood and DNA) from people living with peripheral neuropathy (PN), a condition that affects the nerves and can cause pain and other issues. Why the PNRR Matters Peripheral neuropathy (PN) has many […]

Read More… from Registry’s New Research Findings on Vitamin D

November is Diabetes Awareness Month

Diabetes graphic.

Diabetes is the main cause of peripheral neuropathy. We’re supporting diabetes awareness month by promoting diabetes education. By learning about what can increase your risk of getting diabetes and the signs that show you might have it, you can take steps to prevent it or manage it better. Diabetes facts One in 10 people worldwide […]

Read More… from November is Diabetes Awareness Month

Stress and Peripheral Neuropathy

During these unprecedented times, stress has been even more prevalent in everyday life. For patients with peripheral neuropathy, it is imperative to identify the factors that are causing stress in order to help eliminate those factors as best as one can. Research published in 2017 notes that chronic stress may worsen neuropathic pain. Please be on […]

Read More… from Stress and Peripheral Neuropathy

Running Through the Pain: Finding Strength in the Face of Polyneuropathy

Marathon runner.

Boston Marathon Tragedy: A Day That Changed Everything The television flickered with images of the elite runners and the wheelchair athletes surging forward, the energy of the Boston Marathon palpable even through the screen. It was April 15, 2013, a day etched in my memory. I had watched the runners begin their journey in Hopkinton, […]

Read More… from Running Through the Pain: Finding Strength in the Face of Polyneuropathy

eNews October 2024

FPN E-News.

October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. A common treatment for breast cancer is chemotherapy, which can lead to a side effect known as chemotherapy-induced peripheral neuropathy […]

Read More… from eNews October 2024

Announcing Our New Partnership with Lilly

FPN partnerships.

We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This collaboration, with Lilly’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Collaboration for Impact with Our New […]

Read More… from Announcing Our New Partnership with Lilly

October: Breast Cancer Awareness Month

pink breast cancer ribbon and text that says 70% of chemotherapy patients may develop neurophathy

October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. Key Breast Cancer Facts*: The Importance of Early Detection Early detection can lead to a 99% survival rate**. A […]

Read More… from October: Breast Cancer Awareness Month